| Ticker | EWTX |
|---|---|
| ISIN | US28036F1057 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to add...
El precio actual de Edgewise Therapeutics, Inc. (EWTX) es de 31,58 , con una variación del 1,12%.
Edgewise Therapeutics, Inc. opera en el sector Healthcare, industria Biotechnology.